Scintigraphy in rheumatic diseases

被引:8
作者
Colamussi, P [1 ]
Prandini, N [1 ]
Cittanti, C [1 ]
Feggi, L [1 ]
Giganti, M [1 ]
机构
[1] Univ Ferrara, Azienda Osped, I-44100 Ferrara, Italy
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2004年 / 18卷 / 06期
关键词
scintigraphy; rheumatology;
D O I
10.1016/j.berh.2004.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this review is to summarise the clinical role of nuclear medicine in rheumatology taking into consideration the most specific diagnostic applications and other worthwhile therapeutic contributions. Traditional bone scintigraphy and recent inflammation-targeting radiopharmaceuticals, such as radiolabelled leucocytes and immunoscintigraphy, now allow us to obtain highly sensitive total-body and tomographical imaging information that can be used for the diagnosis of osteoarticular disease. The most common extra-articular manifestations of rheumatic diseases due to digestive, central nervous, respiratory and cardiovascular system involvement can be diagnosed by specific scintigraphic methods. Radiosynovectomy plays an important role in providing effective treatment for some joint diseases that are resistant to pharmacological therapy. Diagnostic and therapeutic applications of nuclear medicine show the highest efficacy in the early phase of rheumatic diseases. In more advanced stages, scintigraphical techniques play a complementary role to radiographical investigations in the assessment of prognosis and therapy efficacy.
引用
收藏
页码:909 / 926
页数:18
相关论文
共 50 条
[31]   The human microbiome in rheumatic autoimmune diseases: A comprehensive review [J].
Coit, Patrick ;
Sawalha, Amr H. .
CLINICAL IMMUNOLOGY, 2016, 170 :70-79
[32]   RHEUMATIC DISEASES IN NEOLITHIC AND MEDIEVAL POPULATIONS OF WESTERN SWITZERLAND [J].
KRAMAR, C ;
LAGIER, R ;
BAUD, CA .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 1990, 49 (06) :338-345
[33]   Peer Support in Rheumatic Diseases: A Narrative Literature Review [J].
Karp, Nathan ;
Yazdany, Jinoos ;
Schmajuk, Gabriela .
PATIENT PREFERENCE AND ADHERENCE, 2023, 17 :2433-2449
[34]   Therapeutic drug monitoring in rheumatic diseases: utile or futile? [J].
Stamp, Lisa K. ;
Barclay, Murray .
RHEUMATOLOGY, 2014, 53 (06) :988-997
[35]   Improving care delivery and outcomes in pediatric rheumatic diseases [J].
Harris, Julia G. ;
Bingham, Catherine A. ;
Morgan, Esi M. .
CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (02) :110-116
[37]   What about rheumatic diseases and COVID-19? [J].
Aouissi, H. A. ;
Belhaouchet, I. .
NEW MICROBES AND NEW INFECTIONS, 2021, 41
[38]   A global perspective on the challenges and opportunities in learning about rheumatic and musculoskeletal diseases in undergraduate medical educationWhite paper by the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD) [J].
Mustafa Al Maini ;
Yousef Al Weshahi ;
Helen E. Foster ;
Mellick J. Chehade ;
Sherine E. Gabriel ;
Jamal Al Saleh ;
Humaid Al Wahshi ;
Johannes W. J. Bijlsma ;
Maurizio Cutolo ;
Sharad Lakhanpal ;
Manda Venkatramana ;
Carlos Pineda ;
Anthony D. Woolf .
Clinical Rheumatology, 2020, 39 :627-642
[39]   Vagus nerve stimulation as a therapeutic option in inflammatory rheumatic diseases [J].
Kocyigit, Burhan Fatih ;
Assylbek, Meirgul I. ;
Akyol, Ahmet ;
Abdurakhmanov, Ruslan ;
Yessirkepov, Marlen .
RHEUMATOLOGY INTERNATIONAL, 2024, 44 (01) :1-8
[40]   COVID-19 in Patients With Rheumatic Diseases Is There a Need to Worry? [J].
Sachdeva, Sonali ;
Manaktala, Pritika ;
Malik, Faizan Ahmad ;
Gupta, Udita ;
Desai, Rupak .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) :E401-E406